Risk of Clostridium difficile diarrhoea in critically ill patients treated with erythromycin-based prokinetic therapy for feed intolerance

Intensive Care Medicine

Volumn 34, Issue 1, 2008, Pages 169-173

  Nguyen, Nam Q ^a,b   Ching, Katrina ^a   Fraser, Robert J ^b,c   Chapman, Marianne J ^a   Holloway, Richard H ^a,b  

^a ROYAL ADELAIDE HOSPITAL   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c REPATRIATION GENERAL HOSPITAL   (Australia)

Author keywords

Antibiotic; Critical illness; Diarrhoea; Enteral nutrition; Feed intolerance; Prokinetic therapy

Indexed keywords

CLOSTRIDIUM DIFFICILE TOXIN A; ERYTHROMYCIN; METOCLOPRAMIDE; PROKINETIC AGENT;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; CLINICAL ASSESSMENT; CLINICAL EXAMINATION; CLOSTRIDIUM DIFFICILE; CRITICALLY ILL PATIENT; DEMOGRAPHY; DIARRHEA; DISEASE DURATION; ENDEMIC DISEASE; FECES ANALYSIS; FEMALE; HIGH RISK PATIENT; HUMAN; INCIDENCE; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MICROSCOPY; NUTRITIONAL INTOLERANCE; OBSERVATIONAL STUDY; PARASITOSIS; PREVALENCE; PROSPECTIVE STUDY; RISK ASSESSMENT;

AUSTRALIA; CLOSTRIDIUM DIFFICILE; CRITICAL ILLNESS; DIARRHEA; DRUG COMBINATIONS; ENTERAL NUTRITION; ENTEROCOLITIS, PSEUDOMEMBRANOUS; ERYTHROMYCIN; FEMALE; GASTROINTESTINAL AGENTS; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 38149098381     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00134-007-0834-5     Document Type: Article

References (20)

1. De Beaux M, Chapman M, Fraser R, Finnis M, De Keulenaer B, Liberalli D, Satanek M (2001) Enteral nutrition in the critically ill: a prospective survey in an Australian intensive care unit. Anaesth Intensive Care 29:619-622
2. Dive A, Moulart M, Jonard P, Jamart J, Mahieu P (1994) Gastroduodenal motility in mechanically ventilated critically ill patients: a manometric study. Crit Care Med 22:441-447
3. Multu G, Multu E, Factor P (2001) Gastrointestinal complications in patients receiving mechanical ventilation. Chest 119:1222-1241
4. Stroud M, Duncan H, Nightingale J (2003) British Society of Gastroenterology. Guidelines for enteral feeding in adult hospital patients. Gut 52(VII):1-12
5. MacLaren R (2000) Intolerance to intragastric enteral nutrition in critically ill patients: complications and management. Pharmacotherapy 20:1486-1498
6. Nguyen NQ, Chapman M, Fraser R, Bryan LK, Holloway RH (2007) Eythromycin is more effective than metoclopramide in the treatment of feed intolerance in critical illness. Crit Care Med 35:483-489
7. Walker AM, Szneke P, Weatherby LB (1999) The risk of serious cardiac arrhythmias among cisapride users in the United Kingdom and Canada. Am J Med 107:356-362
8. Tonini M, De Ponti F, Di Nucci A (1999) Review article: adverse effects of gastrointestinal prokinetics. Aliment Pharmacol Ther 13:1581-1591
9. Guerin J, Leibinger F (2002) Why not to use erythromycin in GI motility. Chest 121:301
10. Dall'Antonia M, Wilks M, Coen PG (2006) Erythromycin for prokinesis: imprudent prescribing? Crit Care 10:112
11. Kelly TW, Patrick MR, Hillman KM (1983) Study of diarrhea in critically ill patients. Crit Care Med 11:7-9
12. Ringel AF, Jameson GL, Foster ES (1995) Diarrhea in the intensive care patient. Crit Care Clin 11:465-477
13. Smith CE, Marien L, Brogdon C, Faust-wilson P, Lohr G, Gerald K, Pingleton S (1990) Diarrhea associated with tube feeding in mechanically ventilated critically ill patients. Nurs Res 39:148-152
14. Nguyen NQ, Chapman M, Fraser R, Bryan LK, Holloway RH (2006) Prokinetic therapy for feed intolerance in critical illness: two drugs better than one? J Gastroenterol Hepatol [Suppl] 130(4):A610
15. McClave SA, Snider HL, Lowen CC, McLaughlin A, Greene L, McCombs R, Rodgers L, Wright R, Roy T, Schumer MP (1992) Use of residual volume as a marker for enteral feeding intolerance: prospective blinded comparison with physical examination and radiographic findings. JPEN J Parenter Enteral Nutr 16:99-105
16. Landry C, Vidon N, Sogni P, Nepveux P, Chaumeil J, Chauvin J, Couturier D, Chaussade S (1995) Effects of erythromycin on gastric emptying, duodeno-caecal transit time, gastric and biliopancreatic secretion during continuous gastric infusion of a liquid diet in healthy volunteers. Eur J Gastroenterol Hepatol 7:797-802
17. Jensen GL, Bross JE, Bourbeau PP (1994) Risk factors for Clostridium difficile stool cytotoxin b among critically ill patients: role of sucralfate. J Infect Dis 170:227-230
18. Hernandez G, Velasco N, Wainstein C, Castillo L, Bugedo G, Maiz A, Lopez F, Guzman S, Vargas C (1999) Gut mucosal atrophy after a short enteral fasting period in critically ill patients. J Crit Care 14:73-77
19. Ritz M, Chapman M, Fraser R, Finnis M, Butler R, Cmielewski P, Davidson G, Rea D (2005) Erythromycin dose of 70mg accelerates gastric emptying as effectively as 200mg in the critically ill. Intensive Care Med 31:949-954
20. Cunningham R, Dale B, Undy B (2003) Proton pump inhibitors as a risk factor for Clostridium difficile diarrhoea. J Hosp Infect 54:243-245